Stay Informed
Sign up to automatically receive Neurocrine Biosciences financial information by email
Webcasts & Presentations
Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.
May 6, 2025
Neurocrine Bioscience to Present at the BofA Securities 2025 Healthcare Conference on May 13
Chief Executive Officer Kyle Gano and Vice-President of Investor Relations Todd Tushla will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025 at 11:20 AM Pacific Time in Las Vegas.
May 6, 2025
Neurocrine Biosciences to Present at the RBCCM Global Healthcare Conference on May 20
Chief Financial Officer Matt Abernethy and Chief Commercial Officer Eric Benevich will present at the RBCCM Global Healthcare Conference on Tuesday, May 20, 2025 at 11:30 AM Eastern Time in New York.
April 14, 2025
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2025 Financial Results
SAN DIEGO, April 14, 2025 - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its first quarter 2025 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on May 5, 2025.
Resources